Clinical Trial Update: Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adebrelimab combined with nab-paclitaxel (albumin-bound paclitaxel) and nedaplatin as neoadjuvant therapy for locally advanced, resecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Albumin Paclitaxel (nab-paclitaxel)
• Nedaplatin (nedaplatin)

Snippet

Sponsor: Harbin Medical University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING